P013 Advances in Clinical Research: Highlights from the Innovation Academy’s Scientific Abstracts
DESCRIPTION
This new session will highlight the most impactful and clinically relevant scientific abstracts submitted to the 2025 Innovation Academy.
LEARNING OBJECTIVES
Present the most impactful scientific abstracts at the 2025 Innovation Academy
Discuss implications of the research findings to clinical practice
SCHEDULE
2:00 PM
Introduction
Sheila Shaigany, MD, FAAD
2:05 PM
Geospatial and Environmental Correlates of Hidradenitis Suppurativa: A Matched Case-Control Analysis
David Gunderman, PhD
2:15 PM
The efficacy and safety of topical 5-fluorouracil in allogeneic hematopoietic stem cell transplant recipients: a multicenter retrospective analysis
Farrah Ezzeddine, MS
2:25 PM
Nail dermoscopy of longitudinal melanonychia in skin of color, an International Dermoscopy Society study
Zasca-Aisha Ristianto
2:35 PM
Racial Differences in Dermatologic Treatment for Adolescents with PCOS-Related Acne Vulgaris
Samantha Garcia
2:45 PM
Investigating the Relationship Between Chronic Inflammatory Skin Disease and Squamous Cell Carcinoma
Amritpal Kooner, MA
2:55 PM
Treatment of Plaque Psoriasis Involving High-Impact Sites With Icotrokinra: Subgroup Analyses of the Phase 3, ICONIC-LEAD Trial
Mark Lebwohl, MD, FAAD
3:05 PM
Pilot Studies testing Oral Baricitinib for Experimental Allergic and Irritant Contact Dermatitis
3:15 PM
Side Effect Profile of Dupilumab in Different Age Groups: Pharmacovigilance Study of the FAERS Database
Robert Adler
3:25 PM
Artificial Intelligence in Dermatopathology: Current Applications, Performance, and Future Integration
Saad Maan
3:35 PM
Inequities in Dupilumab Approval: Wait Times and Social Determinants in Atopic Dermatitis
Mackenzie Joe
3:45 PM
Assessing the Quality-of-Life Impact of Cutaneous Toxicities: A Prospective Cohort Study in Oncology Patients
Ruhi Nayak
SPEAKERS
Robert Adler
SUNY Downstate College of Medicine
Farrah Ezzeddine, MS
Samantha Garcia
Northwestern University Feinberg School of Medicine
Amit Garg, MD, FAAD
Northwell Health
David Gunderman, PhD
Mackenzie Joe
McGovern Medical School at UT Health Houston
Amritpal Kooner, MA
Mark Lebwohl, MD, FAAD
Icahn School of Medicine at Mount Sinai
Saad Maan
Ruhi Nayak
Harvard Medical School
Madison Owens
Departments of Pharmacology and Toxicology, Dermatology, Wright State University, Dayton Ohio
Zasca-Aisha Ristianto
NYU Grossman School of Medicine
Sheila Shaigany, MD, FAAD
Northwell
HANDOUTS
SPEAKER DISCLOSURES
Robert Adler
No financial relationships exist with ineligible companies.
Farrah Ezzeddine, MS
No financial relationships exist with ineligible companies.
Samantha Garcia
No financial relationships exist with ineligible companies.
Amit Garg, MD, FAAD
AbbVie – Advisory Board(Honoraria); Almirall – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria); Insmed Incorporated – Consultant (1099 relationship)(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Sanofi – Data Safety Monitoring Board(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB – Consultant(Honoraria); Zura Bio – Consultant (1099 relationship)(Fees);
David Gunderman, PhD
No financial relationships exist with ineligible companies.
Mackenzie Joe
No financial relationships exist with ineligible companies.
Amritpal Kooner, MA
No financial relationships exist with ineligible companies.
Mark Lebwohl, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Aikium – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); AltruBio Inc. – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Honoraria); Atomwise – Consultant(Honoraria); Avotres, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences, Inc – Consultant(Honoraria); Celltrion – Consultant(Honoraria); Clexio Biosciences, Ltd – Investigator(Grants/Research Funding); CoreEvitas, LLC – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); Dermsquared – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Evommune, Inc. – Consultant(Honoraria); Facilitation of International Dermatology Education – Consultant(Honoraria); Forte Biosciences – Consultant(Honoraria); Galderma – Consultant(Honoraria); Genentech, Inc. – Consultant(Honoraria); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Inozyme Pharma – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Leo Pharma A/S – Consultant(Honoraria); Mayne Pharma Group – Consultant (1099 relationship)(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Honoraria); Mindera – Consultant(Honoraria); Mirum Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria); New York College of Podiatric Medicine – Speaker/Faculty Education(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Revolo Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Seanergy Maritime Holdings Corp. – Consultant(Honoraria); Strata Skin Sciences – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Trevi Therapeutics – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Consultant(Honoraria);
Saad Maan
No financial relationships exist with ineligible companies.
Ruhi Nayak
No financial relationships exist with ineligible companies.
Madison Owens
No financial relationships exist with ineligible companies.
Zasca-Aisha Ristianto
No financial relationships exist with ineligible companies.
Sheila Shaigany, MD, FAAD
Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(No Compensation Received); Hoth Therapeutics – Investigator(No Compensation Received);